Bristol-Myers Squibb and Samsung BioLogics expand manufacturing agreement
Bristol-Myers and Samsung BioLogics announced the companies will increase the scope of their existing manufacturing agreement in which Samsung will manufacture commercial drug substances and drug product for several Bristol-Myers Squibb biologic medicines at its Incheon manufacturing site. April 22, 2014